Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Beloon Big Pharma voor goed gedrag

In NRC Next, Wim Leereveld’s opiniated article, on how to influence pharmaceutical companies policies and practices to increase access to medicine, was published. NRC Next is a Dutch daily, that specifically targets a younger, well educated audience. The article refers to ‘Morgen 2011’ (Tomorrow 2011), where Wim is one of speakers at May 21, 2011.

Date

17 May 2011

Direct links

Read the full article

Ouder dan veertig werd je in 1811 meestal niet in Nederland. Dat is nu gelukkig heel anders. De afgelopen twee eeuwen is de gezondheidszorg gigantisch verbeterd, in Nederland en in de wereld. Maar niet overal, en niet voor iedereen. Nog steeds hebben twee miljard mensen in ontwikkelingslanden geen toegang tot betaalbare medicijnen. Ze sterven te vroeg, aan ziekten waar niemand nog aan hoeft te overlijden. Heb je de pech in Congo te leven en je loopt een flinke longontsteking op, dan is de kans klein dat er voor jou betaalbare antibiotica te koop zijn. Zo blijft de gemiddelde levensverwachting in dit land, anno 2011, op 40 jaar steken.

Read the full article on NRC Next 

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved